PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing...

To Support Targeted Commercialization and Global Partnering of FDA-Approved Non-Drug Treatment for Pediatric ADHD LOS ANGELES, Sept. 21,...

Led by Checkmate Capital Group Development of Biomaterial-based Neurovascular Stent and Platform for Local Delivery of Cell Therapies LOS...

LOS ANGELES, March 16, 2020 (GLOBE NEWSWIRE) -- Checkmate Capital Group, LLC (“Checkmate”) is pleased to announce that it is moving its...